Harilal Patel

Pharmacokinetics, Safety, and Tolerability of Saroglitazar (ZYH1), a Predominantly PPARα Agonist with Moderate PPARγ Agonist Activity in Healthy Human Subjects

H. Patel, Rajendra H. Jani, Kevinkumar Kansagra, 2013, Clinical Drug Investigation.

Diaryl dihydropyrazole-3-carboxamides with significant in vivo antiobesity activity related to CB1 receptor antagonism: synthesis, biological evaluation, and molecular modeling in the homology model.

Bhupendra Mishra, B. Pandey, Bhupendra Mishra, 2007, Journal of medicinal chemistry.

Pharmacokinetics , Safety , and Tolerability of Saroglitazar ( ZYH 1 ) , a Predominantly PPAR a Agonist with Moderate PPAR c Agonist Activity in Healthy Human Subjects

Rajendra H. Jani, Kevinkumar Kansagra, Mukul R. Jain, 2013 .

A sensitive quantitative assay for the determination of propafenone and two metabolites, 5-hydroxypropafenone and N-depropylpropafenone, in human K2EDTA plasma using LC-MS/MS with ESI operated in positive mode.

Nuggehally R Srinivas, H. Patel, Shaival Shah, 2017, Biomedical chromatography : BMC.